SCHEMBL17294178

SCHEMBL17294178

CN1C(=O)C(Cc2ccc(Cl)cc2)C(=O)N(C)C1=O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.62
MAPT P10636 9/20 0.62
HSD17B10 Q99714 7/20 0.62
KMT2A Q03164 5/20 0.62
MEN1 O00255 4/20 0.62
GAA P10253 4/20 0.62
L3MBTL1 Q9Y468 3/20 0.62
THRB P10828 2/20 0.62
RECQL P46063 1/20 0.62
KDM4C Q9H3R0 4/20 0.59
POLB P06746 3/20 0.59
KDM4A O75164 2/20 0.59
USP2 O75604 2/20 0.59
ALOX15 P16050 1/20 0.59
CACNA1B Q00975 1/20 0.56
APBA1 Q02410 1/20 0.56
KDM4E B2RXH2 2/20 0.49
HPGD P15428 2/20 0.49
EP300 Q09472 1/20 0.45
ALOX12 P18054 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17717914 0.91 ALDH1A1 (0.72) ALDH1A1MAPTHSD17B10KMT2AMEN1
SCHEMBL15978256 0.82 ALDH1A1 (0.62) ALDH1A1MAPTHSD17B10KMT2AMEN1
SCHEMBL31424239 0.82 ALDH1A1 (0.62) ALDH1A1MAPTHSD17B10KMT2AMEN1
SCHEMBL4435666 0.81 KMT2A (0.72) ALDH1A1MAPTHSD17B10KMT2AMEN1
SCHEMBL17358747 0.79 KMT2A (0.65) ALDH1A1MAPTHSD17B10KMT2AMEN1
SCHEMBL17294179 0.79 L3MBTL1 (0.68) ALDH1A1MAPTHSD17B10KMT2AMEN1
SCHEMBL31006368 0.77 ALDH1A1 (1.00) ALDH1A1MAPTHSD17B10KMT2AMEN1
SCHEMBL15978122 0.76 MAPT (0.60) ALDH1A1MAPTHSD17B10KMT2AMEN1
SCHEMBL17717913 0.73 KMT2A (0.62) ALDH1A1MAPTHSD17B10KMT2AMEN1
SCHEMBL17717935 0.73 KMT2A (0.61) ALDH1A1MAPTHSD17B10KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3148983-A1 N-HYDROXYLAMINO-BARBITURIC ACID DERIVATIVES AS NITROXYL DONORS The Johns Hopkins University (US) 2017-04-05 EP disclosed
US-9464061-B2 N-hydroxylamino-barbituric acid derivatives THE JOHNS HOPKINS UNIVERSITY (US) 2016-10-11 US disclosed
US-20160060229-A1 N-HYDROXYLAMINO-BARBITURIC ACID DERIVATIVES NATIONAL SCIENCE FOUNDATION 2016-03-03 US disclosed
WO-2015183838-A1 N-HYDROXYLAMINO-BARBITURIC ACID DERIVATIVES AS NITROXYL DONORS THE JOHNS HOPKINS UNIVERSITY (US) 2015-12-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160060229-A1 N-HYDROXYLAMINO-BARBITURIC ACID DERIVATIVES TNNT2, TNNI3, TNNC1 ALDH1A1 654/4885MAPT 2796/4885HSD17B10 607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.